The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Prognosis of Carcinoid Heart Disease: Analysis of 200 Cases Over Two Decades
Open accessAbstract
Background— The long-term prognosis of patients who develop carcinoid heart disease and the effect of cardiac surgery on outcome are not well established. Methods and Results— In this retrospective study, we identified 200 patients with carcinoid syndrome referred for echocardiography in whom the diagnosis of carcinoid heart disease was confirmed. Patients were divided into 3 groups of similar size according to the date from first diagnosis of carcinoid heart disease. Group A comprised patients diagnosed from 1981 through June 1989; group B, diagnosed July 1989 through May 1995; and group C, June 1995 through 2000. The end point was all-cause mortality. Median survival was significantly lower in group A (1.5 years, 95% CI 1.1 to 1.9 years) compared with groups B (3.2, 95% CI 1.3 to 5.1 years) and C (4.4, 95% CI 2.4 to 7.1 years; P =0.009). In a multivariate model adjusted for treatment and clinical characteristics, the risk of death in groups B (hazard ratio 0.67, 95% CI 0.46 to 0.99, P =0.04) and C (hazard ratio 0.61, 95% CI 0.39 to 0.92, P =0.006) was significantly reduced relative to group A. Cardiac surgery was performed in 87 patients. When cardiac surgery was included as a time-dependent covariate in a multivariate analysis, it was associated with a risk reduction of 0.48 (95% CI 0.31 to 0.73, P <0.001), whereas the time period of diagnosis was no longer significant. Conclusions— The prognosis of patients with recognized carcinoid heart disease has improved over the past 2 decades at our institution. This change in survival may be related to valve replacement surgery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Treatment of the Malignant Carcinoid Syndrome
Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., & Hahn, R. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151102 · Cited by 849
Self-citationKulke, M. H., & Mayer, R. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903183401107 · Cited by 741
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
Pellikka, P. A., Tajik, A. J., Khandheria, B. K., Seward, J. B., Callahan, J. A., Pitot, H. C., & Kvols, L. K. (1993) · Circulation · doi:10.1161/01.cir.87.4.1188 · Cited by 614
Self-citationRobiolio, P. A., Rigolin, V. H., Wilson, J. S., Harrison, J. K., Sanders, L. L., Bashore, T. M., & Feldman, J. M. (1995) · Circulation · doi:10.1161/01.cir.92.4.790 · Cited by 406
Rubin, J., Ajani, J., Schirmer, W., Venook, A. P., Bukowski, R., Pommier, R., Saltz, L., Dandona, P., & Anthony, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 389
Self-citationFactors Associated with Progression of Carcinoid Heart Disease
Møller, J. E., Connolly, H. M., Rubin, J., Seward, J. B., Modesto, K., & Pellikka, P. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021451 · Cited by 298
Self-citationDi Bartolomeo, M., Bajetta, E., Buzzoni, R., Mariani, L., Carnaghi, C., Somma, L., Zilembo, N., Di Leo, A., & ITMO Association (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960115)77:2<402::aid-cncr25>3.0.co;2-4 · Cited by 296
Cardiac Grafting of Engineered Heart Tissue in Syngenic Rats
Zimmermann, W.-H., Didié, M., Wasmeier, G. H., Nixdorff, U., Hess, A., Melnychenko, I., Boy, O., Neuhuber, W. L., Weyand, M., & Eschenhagen, T. (2002) · Circulation · doi:10.1161/01.cir.0000032876.55215.10 · Cited by 292
Kubota, A., Yamada, Y., Kagimoto, S., Shimatsu, A., Imamura, M., Tsuda, K., Imura, H., Seino, S., & Seino, Y. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117090 · Cited by 269
Outcome of cardiac surgery for carcinoid heart disease
Connolly, H. M., Nishimura, R. A., Smith, H. C., Pellikka, P. A., Mullany, C. J., & Kvols, L. K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00374-y · Cited by 202
Self-citationChemotherapy and biotherapy in the treatment of neuroendocrine tumours
Öberg, K. (2001) · Annals of Oncology · doi:10.1093/annonc/12.suppl_2.s111 · Cited by 167
Simula, D. V., Edwards, W. D., Tazelaar, H. D., Connolly, H. M., & Schaff, H. V. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.2.139 · Cited by 135
Self-citationPrediction of prognosis by echocardiography in patients with midgut carcinoid syndrome
Westberg, G., Wängberg, B., Ahlman, H. K., Bergh, C. ‐., Suurküla, M. B., & Caidahl, K. (2001) · British journal of surgery · doi:10.1046/j.0007-1323.2001.01798.x · Cited by 121
A Phase II study of high-dose paclitaxel in patients with advanced neuroendocrine tumors
Ansell, S. M., Pitot, H. C., Burch, P. A., Kvols, L. K., Mahoney, M. R., & Rubin, J. (2001) · Cancer · doi:10.1002/1097-0142(20010415)91:8<1543::aid-cncr1163>3.0.co;2-n · Cited by 107
Self-citationCell proliferation in carcinoid valve disease: a mechanism for serotonin effects.
Rajamannan, N. M., Caplice, N. M., Anthikad, F., Sebo, T. J., Orszulak, T. A., Wd, E., Tajik, J. A., & Schwartz, R. S. (2001) · PubMed · Cited by 96
Öberg, K., Norheim, I., Lundqvist, G., & WIDE, L. E. (1987) · Acta Oncologica · doi:10.3109/02841868709113712 · Cited by 92
Predictors of outcome of tricuspid valve replacement in carcinoid heart disease
Robiolio, P. A., Rigolin, V. H., Harrison, J. K., Lowe, J. E., Moore, J. O., Bashore, T. M., & Feldman, J. M. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80586-4 · Cited by 81
Connolly, H. M., Schaff, H. V., Mullany, C. J., Abel, M., & Pellikka, P. A. (2003) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)01068-1 · Cited by 65
Self-citationLeong, W. L., & Pasieka, J. L. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10062 · Cited by 63
Roy, A., Nj, B., & Mh, Y. (2000) · PubMed · Cited by 56
Cited by
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 1,982
Metadata
- Authors
- Møller, J. E., Pellikka, P. A., Bernheim, A. M., Schaff, H. V., Rubin, J., & Connolly, H. M.
- Venue
- Circulation
- Published
- 2005-11-22
- Volume
- 112
- Issue
- 21
- Pages
- 3320-3327
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2162781575
- Cited by
- 278
- References
- 21
- FWCI
- 4.80
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.